• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄病毒NS1及其在疫苗开发中的潜力。

Flavivirus NS1 and Its Potential in Vaccine Development.

作者信息

Carpio Kassandra L, Barrett Alan D T

机构信息

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.

出版信息

Vaccines (Basel). 2021 Jun 9;9(6):622. doi: 10.3390/vaccines9060622.

DOI:10.3390/vaccines9060622
PMID:34207516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8229460/
Abstract

The Flavivirus genus contains many important human pathogens, including dengue, Japanese encephalitis (JE), tick-borne encephalitis (TBE), West Nile (WN), yellow fever (YF) and Zika (ZIK) viruses. While there are effective vaccines for a few flavivirus diseases (JE, TBE and YF), the majority do not have vaccines, including WN and ZIK. The flavivirus nonstructural 1 (NS1) protein has an unusual structure-function because it is glycosylated and forms different structures to facilitate different roles intracellularly and extracellularly, including roles in the replication complex, assisting in virus assembly, and complement antagonism. It also plays a role in protective immunity through antibody-mediated cellular cytotoxicity, and anti-NS1 antibodies elicit passive protection in animal models against a virus challenge. Historically, NS1 has been used as a diagnostic marker for the flavivirus infection due to its complement fixing properties and specificity. Its role in disease pathogenesis, and the strong humoral immune response resulting from infection, makes NS1 an excellent target for inclusion in candidate flavivirus vaccines.

摘要

黄病毒属包含许多重要的人类病原体,包括登革热病毒、日本脑炎病毒(JE)、蜱传脑炎病毒(TBE)、西尼罗河病毒(WN)、黄热病病毒(YF)和寨卡病毒(ZIK)。虽然有针对几种黄病毒疾病(JE、TBE和YF)的有效疫苗,但大多数黄病毒疾病(包括WN和ZIK)没有疫苗。黄病毒非结构蛋白1(NS1)具有不同寻常的结构功能,因为它是糖基化的,并且会形成不同的结构以在细胞内和细胞外发挥不同作用,包括在复制复合体中的作用、协助病毒组装以及补体拮抗作用。它还通过抗体介导的细胞毒性在保护性免疫中发挥作用,并且抗NS1抗体在动物模型中可引发针对病毒攻击的被动保护作用。从历史上看,由于NS1的补体固定特性和特异性,它一直被用作黄病毒感染的诊断标志物。其在疾病发病机制中的作用以及感染所引发的强烈体液免疫反应,使得NS1成为候选黄病毒疫苗中的一个极佳靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b01/8229460/6e96dbbe8316/vaccines-09-00622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b01/8229460/1a7942416e98/vaccines-09-00622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b01/8229460/6e96dbbe8316/vaccines-09-00622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b01/8229460/1a7942416e98/vaccines-09-00622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b01/8229460/6e96dbbe8316/vaccines-09-00622-g002.jpg

相似文献

1
Flavivirus NS1 and Its Potential in Vaccine Development.黄病毒NS1及其在疫苗开发中的潜力。
Vaccines (Basel). 2021 Jun 9;9(6):622. doi: 10.3390/vaccines9060622.
2
Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.福尔马林灭活全病毒和重组亚单位黄病毒疫苗。
Adv Virus Res. 2003;61:395-418. doi: 10.1016/s0065-3527(03)61010-9.
3
Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections.既往异源黄病毒疫苗接种对蜱传脑炎和登革热病毒感染人体抗体应答的影响。
J Med Virol. 2023 Nov;95(11):e29245. doi: 10.1002/jmv.29245.
4
Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.嵌合黄病毒:针对登革热、蜱传脑炎和日本脑炎的新型疫苗。
Adv Virus Res. 2003;61:469-509. doi: 10.1016/s0065-3527(03)61013-4.
5
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.一种嵌合日本脑炎疫苗可预防致死性黄热病病毒感染而不诱导中和抗体。
mBio. 2020 Apr 7;11(2):e02494-19. doi: 10.1128/mBio.02494-19.
6
Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.人类对17D黄热病疫苗和灭活蜱传脑炎疫苗免疫接种的抗体反应。
J Med Virol. 1985 Sep;17(1):35-45. doi: 10.1002/jmv.1890170106.
7
Flavivirus NS1: a multifaceted enigmatic viral protein.黄病毒NS1:一种具有多面性的神秘病毒蛋白。
Virol J. 2016 Jul 29;13:131. doi: 10.1186/s12985-016-0590-7.
8
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.在美国,使用乙型脑炎病毒或黄热病病毒疫苗进行初免成年人中,一种纯化的灭活寨卡病毒候选疫苗的安全性和免疫原性:一项 1 期、随机、双盲、安慰剂对照临床试验。
Lancet Infect Dis. 2023 Oct;23(10):1175-1185. doi: 10.1016/S1473-3099(23)00192-5. Epub 2023 Jun 27.
9
Antibody ratios against NS1 antigens of tick-borne encephalitis and West Nile viruses support differential flavivirus serology in dogs.针对蜱传脑炎和西尼罗河病毒 NS1 抗原的抗体比值支持犬类中不同黄病毒血清学检测。
Transbound Emerg Dis. 2022 Sep;69(5):e2789-e2799. doi: 10.1111/tbed.14630. Epub 2022 Jul 1.
10
The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.抗黄热病毒NS1抗体的Fc部分是小鼠抵抗黄热脑炎的保护决定因素。
Virology. 1993 Jan;192(1):132-41. doi: 10.1006/viro.1993.1015.

引用本文的文献

1
A Scoping Review of Preclinical Research on Monoclonal Antibody Development for Prophylaxis and Treatment of West Nile Virus Infections.用于预防和治疗西尼罗河病毒感染的单克隆抗体开发的临床前研究范围综述
Viruses. 2025 Jun 12;17(6):845. doi: 10.3390/v17060845.
2
Pathogenicity and virulence of Powassan virus.波瓦桑病毒的致病性和毒力
Virulence. 2025 Dec;16(1):2523887. doi: 10.1080/21505594.2025.2523887. Epub 2025 Jun 26.
3
Attenuating Mutations in Usutu Virus: Towards Understanding Orthoflavivirus Virulence Determinants and Live Attenuated Vaccine Design.

本文引用的文献

1
Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity.日本脑炎病毒减毒活疫苗株表现出改变的免疫原性、毒力和遗传多样性。
NPJ Vaccines. 2021 Sep 2;6(1):112. doi: 10.1038/s41541-021-00371-y.
2
Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc Receptor-Dependent and -Independent Pathways.抗寨卡病毒 NS1 蛋白的单克隆抗体通过 Fc 受体依赖性和非依赖性途径发挥保护作用。
mBio. 2021 Feb 9;12(1):e03179-20. doi: 10.1128/mBio.03179-20.
3
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial.
乌苏图病毒中的减毒突变:迈向了解黄病毒属病毒毒力决定因素和减毒活疫苗设计
Vaccines (Basel). 2025 May 3;13(5):495. doi: 10.3390/vaccines13050495.
4
Structural basis of Zika virus NS1 multimerization and human antibody recognition.寨卡病毒NS1多聚化及人源抗体识别的结构基础
Npj Viruses. 2024 Apr 25;2(1):14. doi: 10.1038/s44298-024-00024-6.
5
Partial protective efficacy of the current licensed Japanese encephalitis live vaccine against the emerging genotype I Japanese encephalitis virus isolated from sheep.目前已获许可的日本脑炎活疫苗对从绵羊中分离出的新兴基因I型日本脑炎病毒的部分保护效力。
Front Immunol. 2025 Feb 13;16:1513261. doi: 10.3389/fimmu.2025.1513261. eCollection 2025.
6
Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses.针对新出现和再次出现的黄病毒的动物模型、治疗方法及疫苗策略
Viruses. 2024 Dec 24;17(1):1. doi: 10.3390/v17010001.
7
RNA elements required for the high efficiency of West Nile virus-induced ribosomal frameshifting.西尼罗河病毒诱导核糖体移码高效发生所需的RNA元件。
Nucleic Acids Res. 2025 Jan 24;53(3). doi: 10.1093/nar/gkae1248.
8
Neurological Complications Associated With the Powassan Virus and Treatment Interventions.与波瓦桑病毒相关的神经系统并发症及治疗干预措施
Cureus. 2024 Oct 18;16(10):e71780. doi: 10.7759/cureus.71780. eCollection 2024 Oct.
9
A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.一剂环状 RNA 疫苗可预防寨卡病毒感染,而不会加重小鼠登革热的严重程度。
Nat Commun. 2024 Oct 16;15(1):8932. doi: 10.1038/s41467-024-53242-0.
10
The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics.黄病毒非结构蛋白5(NS5):结构、功能以及疫苗和治疗药物研发的靶点
Vaccines (Basel). 2024 Aug 1;12(8):865. doi: 10.3390/vaccines12080865.
伊维菌素加速成人登革热患者循环非结构蛋白 1(NS1)清除:一项联合 2/3 期随机双盲安慰剂对照试验。
Clin Infect Dis. 2021 May 18;72(10):e586-e593. doi: 10.1093/cid/ciaa1332.
4
Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction.抗体抑制黄病毒NS1触发的内皮功能障碍的结构基础。
Science. 2021 Jan 8;371(6525):194-200. doi: 10.1126/science.abc0476.
5
A broadly protective antibody that targets the flavivirus NS1 protein.一种广泛保护性的抗体,针对黄病毒 NS1 蛋白。
Science. 2021 Jan 8;371(6525):190-194. doi: 10.1126/science.abb9425.
6
Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1.登革病毒非结构蛋白1通过延缓半胱天冬酶介导的Beclin-1裂解来维持自噬。
Int J Mol Sci. 2020 Dec 19;21(24):9702. doi: 10.3390/ijms21249702.
7
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy.针对 NS1 细胞表面表位的抗体可预防妊娠期寨卡病毒感染。
Nat Commun. 2020 Oct 19;11(1):5278. doi: 10.1038/s41467-020-19096-y.
8
Identification of a protective epitope in Japanese encephalitis virus NS1 protein.鉴定日本脑炎病毒 NS1 蛋白中的保护性表位。
Antiviral Res. 2020 Oct;182:104930. doi: 10.1016/j.antiviral.2020.104930. Epub 2020 Sep 6.
9
A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.一种缺失NS1的复制缺陷型日本脑炎病毒(JEV)候选疫苗可在小鼠中对JEV和西尼罗河病毒提供双重保护。
NPJ Vaccines. 2020 Aug 5;5(1):73. doi: 10.1038/s41541-020-00220-4. eCollection 2020.
10
Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection.宿主炎症细胞因子和免疫相关代谢物与登革病毒感染疾病严重程度的相关性,而不是病毒 NS1 蛋白。
PLoS One. 2020 Aug 7;15(8):e0237141. doi: 10.1371/journal.pone.0237141. eCollection 2020.